EQS-News: Marinomed Biotech AG evaluates strategic options for Carragelose portfolio
EQS-News: Marinomed Biotech AG / Key word(s): Strategic Company Decision
Marinomed Biotech AG evaluates strategic options for Carragelose portfolio
18.12.2023 / 08:33 CET/CEST
The issuer is solely responsible for the content of this announcement.
═══════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════
Marinomed Biotech AG evaluates strategic options for Carragelose portfolio
• Marinomed evaluates strategic!-->…